Published in World J Gastroenterol on January 07, 2012
Safety and Efficacy of Long Limb Roux-en Y Reconstruction (LoLiRoRe) | NCT01373346
Long Term Diabetes Improvement After Cancer Gastrectomy and Colectomy | NCT01518023
Predictive factors of type 2 diabetes mellitus remission following bariatric surgery: a meta-analysis. Obes Surg (2015) 1.55
Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes. Diabetes Care (2012) 1.22
Impact of bariatric surgery on ghrelin and obestatin levels in obesity or type 2 diabetes mellitus rat model. J Diabetes Res (2014) 0.85
Roux-en-Y gastric bypass for Chinese type 2 diabetes mellitus patients with a BMI < 28 kg/m(2): a multi-institutional study. J Biomed Res (2015) 0.83
Recent advances in bariatric/metabolic surgery: appraisal of clinical evidence. J Biomed Res (2014) 0.82
Resolution of type 2 diabetes after gastrectomy for gastric cancer with long limb Roux-en Y reconstruction: a prospective pilot study. J Korean Surg Soc (2013) 0.82
Improvement of type 2 diabetes mellitus after gastric cancer surgery: short-term outcome analysis after gastrectomy. World J Gastroenterol (2013) 0.81
Bariatric surgery and diabetes remission: Who would have thought it? Indian J Endocrinol Metab (2015) 0.80
Bariatric Surgery for Type 2 Diabetes Mellitus in Patients with BMI <30 kg/m2: A Systematic Review and Meta-Analysis. PLoS One (2015) 0.79
Impact of pre-existing type-2 diabetes on patient outcomes after radical resection for gastric cancer: a retrospective cohort study. Dig Dis Sci (2013) 0.79
Does Roux-en-Y gastrectomy for gastric cancer influence glucose homeostasis in lean patients? Surg Endosc (2013) 0.77
Gastrointestinal dopamine as an anti-incretin and its possible role in bypass surgery as therapy for type 2 diabetes with associated obesity. Minerva Endocrinol (2015) 0.75
The effect of long Roux-en-Y gastrojejunostomy in gastric cancer patients with type 2 diabetes and body mass index < 35 kg/m(2): preliminary results. Ann Surg Treat Res (2015) 0.75
Improvement of diabetes and hypertension after gastrectomy: a nationwide cohort study. World J Gastroenterol (2015) 0.75
Metabolic Surgery in Korea: What to Consider before Surgery. Endocrinol Metab (Seoul) (2017) 0.75
Gastric bypass procedure for type 2 diabetes patients with BMI <28 kg/m(2). Surg Endosc (2016) 0.75
Outcome after curative surgery for gastric cancer patients with type 2 diabetes. World J Surg (2014) 0.75
Bariatric surgery: a systematic review and meta-analysis. JAMA (2004) 23.34
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med (2004) 17.91
Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med (2009) 13.91
Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg (2003) 6.50
The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg (2010) 3.37
A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. World Health Organization DIAMOND Project Group. Diabetologia (1993) 3.35
Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diabetes Care (2008) 2.10
Potential of surgery for curing type 2 diabetes mellitus. Ann Surg (2002) 1.88
A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? Ann Surg (1998) 1.61
Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus. Nat Rev Endocrinol (2010) 1.37
Effects of obesity surgery on non-insulin-dependent diabetes mellitus. Arch Surg (2002) 1.19
The amelioration of diabetes mellitus following subtotal gastrectomy. Surg Gynecol Obstet (1955) 1.17
Role of the incretin system in the remission of type 2 diabetes following bariatric surgery. Nutr Metab Cardiovasc Dis (2008) 1.00
Why is type 1 diabetes uncommon in Asia? Ann N Y Acad Sci (2006) 0.97
Effects of subtotal gastrectomy and Roux-en-Y gastrojejunostomy on the clinical outcome of type 2 diabetes mellitus. J Surg Res (2010) 0.96
Amelioration of diabetes mellitus following gastric resection. Acta Med Scand (1961) 0.93
Neuro-modulation and bariatric surgery for type 2 diabetes mellitus. Int J Clin Pract Suppl (2010) 0.92
Evolution of type 2 diabetes mellitus in non morbid obese gastrectomized patients with Roux en-Y reconstruction: retrospective study. World J Surg (2010) 0.91
Effects of obesity surgery on type 2 diabetes mellitus Asian patients. World J Surg (2009) 0.85
Safety, effectiveness, and cost effectiveness of metabolic surgery in the treatment of type 2 diabetes mellitus. J Obes (2010) 0.81
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet (2012) 6.83
Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report--a phase III multicenter, prospective, randomized Trial (KLASS Trial). Ann Surg (2010) 4.89
Long-term results of laparoscopic gastrectomy for gastric cancer: a large-scale case-control and case-matched Korean multicenter study. J Clin Oncol (2014) 4.79
Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy. Gastroenterology (2011) 2.36
The impact of comorbidity on surgical outcomes in laparoscopy-assisted distal gastrectomy: a retrospective analysis of multicenter results. Ann Surg (2008) 2.33
Defining surgical quality in gastric cancer: a RAND/UCLA appropriateness study. J Am Coll Surg (2013) 2.19
Robotic gastrectomy as an oncologically sound alternative to laparoscopic resections for the treatment of early-stage gastric cancers. Arch Surg (2011) 2.16
Long-term outcomes after laparoscopy-assisted gastrectomy for advanced gastric cancer: a large-scale multicenter retrospective study. Surg Endosc (2011) 1.85
Gene expression signature-based prognostic risk score in gastric cancer. Clin Cancer Res (2011) 1.83
Laparoscopic spleen-preserving splenic hilar lymph node dissection during total gastrectomy for gastric cancer. J Am Coll Surg (2008) 1.80
Role of robotic gastrectomy using da Vinci system compared with laparoscopic gastrectomy: initial experience of 20 consecutive cases. Surg Endosc (2009) 1.80
Early gastric cancer of signet ring cell carcinoma is more amenable to endoscopic treatment than is early gastric cancer of poorly differentiated tubular adenocarcinoma in select tumor conditions. Surg Endosc (2011) 1.71
Adverse effects of perioperative transfusion on patients with stage III and IV gastric cancer. Ann Surg Oncol (2002) 1.71
Robot-assisted gastrectomy with lymph node dissection for gastric cancer: lessons learned from an initial 100 consecutive procedures. Ann Surg (2009) 1.71
Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography. Cancer (2005) 1.70
Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT. J Nucl Med (2005) 1.70
Long-term oncologic outcomes of 714 consecutive laparoscopic gastrectomies for gastric cancer: results from the 7-year experience of a single institute. Surg Endosc (2011) 1.64
Combined inhibition of c-Src and epidermal growth factor receptor abrogates growth and invasion of head and neck squamous cell carcinoma. Clin Cancer Res (2008) 1.63
Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line set. Mol Cancer Ther (2010) 1.62
Optimal management of gastric cancer: results from an international RAND/UCLA expert panel. Ann Surg (2014) 1.61
Oral vitamin B12 replacement: an effective treatment for vitamin B12 deficiency after total gastrectomy in gastric cancer patients. Ann Surg Oncol (2011) 1.58
Zinc deficiency may be a cause of burning mouth syndrome as zinc replacement therapy has therapeutic effects. J Oral Pathol Med (2010) 1.55
Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute. Ann Surg Oncol (2007) 1.53
Frequent mutations of human Mad2, but not Bub1, in gastric cancers cause defective mitotic spindle checkpoint. Mutat Res (2005) 1.51
Laparoscopic resection of a huge intraluminal gastric submucosal tumor located in the anterior wall: eversion method. J Surg Oncol (2005) 1.46
Risk factors associated with complication following laparoscopy-assisted gastrectomy for gastric cancer: a large-scale korean multicenter study. Ann Surg Oncol (2008) 1.42
Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer. Gut (2012) 1.42
Cross-species hybridization of microarrays for studying tumor transcriptome of brain metastasis. Proc Natl Acad Sci U S A (2011) 1.41
Metabolic syndrome is an independent risk factor for synchronous colorectal neoplasm in patients with gastric neoplasm. J Gastroenterol Hepatol (2012) 1.41
Mesenchymal neoplasms of the major salivary glands: clinicopathological features of 18 cases. Eur Arch Otorhinolaryngol (2007) 1.41
CT and PET in stomach cancer: preoperative staging and monitoring of response to therapy. Radiographics (2006) 1.41
Participation and conflict in the decision-making process for endoscopic resection or surgical gastrectomy for early gastric cancer. J Surg Oncol (2012) 1.40
Prognostic impact of lymphatic and/or blood vessel invasion in patients with node-negative advanced gastric cancer. Ann Surg Oncol (2002) 1.40
Basal cell adenocarcinoma of the salivary gland: a morphological and immunohistochemical comparison with basal cell adenoma with and without capsular invasion. Diagn Pathol (2013) 1.39
Early gastric carcinoma with signet ring cell histology. Cancer (2002) 1.39
Is gastrectomy mandatory for all residual or recurrent gastric cancer following endoscopic resection? A large-scale Korean multi-center study. J Surg Oncol (2008) 1.38
Application of minimally invasive treatment for early gastric cancer. J Surg Oncol (2004) 1.37
Advanced gastric carcinoma with signet ring cell histology. Oncology (2007) 1.35
Changes in treatment outcomes of gastric cancer surgery over 45 years at a single institution. Yonsei Med J (2008) 1.34
Safety and efficacy of fast-track surgery in laparoscopic distal gastrectomy for gastric cancer: a randomized clinical trial. World J Surg (2012) 1.31
Clinicopathological aspects and prognostic value with respect to age: an analysis of 3,362 consecutive gastric cancer patients. J Surg Oncol (2009) 1.30
Survival benefit of metastasectomy for Krukenberg tumors from gastric cancer. Gynecol Oncol (2004) 1.29
Metastatic carcinomas to the oral cavity and oropharynx. Korean J Pathol (2012) 1.27
Intraoperative portable abdominal radiograph for tumor localization: a simple and accurate method for laparoscopic gastrectomy. Surg Endosc (2010) 1.27
Recurrence following laparoscopy-assisted gastrectomy for gastric cancer: a multicenter retrospective analysis of 1,417 patients. Ann Surg Oncol (2010) 1.24
Current management and future strategies of gastric cancer. Yonsei Med J (2012) 1.23
The impact of a high body mass index on laparoscopy assisted gastrectomy for gastric cancer. Surg Endosc (2009) 1.21
Complications requiring reoperation after gastrectomy for gastric cancer: 17 years experience in a single institute. J Gastrointest Surg (2008) 1.20
Analysis of demographic characteristics in 3242 young age gastric cancer patients in Korea. World J Gastroenterol (2010) 1.19
Randomized controlled trial comparing gastrectomy plus chemotherapy with chemotherapy alone in advanced gastric cancer with a single non-curable factor: Japan Clinical Oncology Group Study JCOG 0705 and Korea Gastric Cancer Association Study KGCA01. Jpn J Clin Oncol (2008) 1.19
Prognostic significance of metastatic lymph node ratio in T3 gastric cancer. World J Surg (2001) 1.18
Menetrier's disease in korea: report of two cases and review of cases in a gastric cancer prevalent region. Yonsei Med J (2004) 1.18
The effect of spleen-preserving lymphadenectomy on surgical outcomes of locally advanced proximal gastric cancer. J Surg Oncol (2009) 1.17
Endoscopic resection for undifferentiated early gastric cancer. Gastrointest Endosc (2009) 1.15
Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors. Oral Oncol (2008) 1.15
Risk factors for lymph node metastasis in undifferentiated early gastric cancer. Ann Surg Oncol (2007) 1.13
Early experiences of robotic-assisted laparoscopic liver resection. Yonsei Med J (2008) 1.13
Comparison of gastric cancer surgery with versus without nasogastric decompression. Yonsei Med J (2002) 1.12
Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Oral Oncol (2007) 1.11
Robotic versus Laparoscopic versus Open Gastrectomy: A Meta-Analysis. J Gastric Cancer (2013) 1.11
Rapid adaptation of robotic gastrectomy for gastric cancer by experienced laparoscopic surgeons. Surg Endosc (2011) 1.11
Prediction of recurrence of early gastric cancer after curative resection. Ann Surg Oncol (2009) 1.10
A prognostic model to predict clinical outcome in gastric cancer patients with bone metastasis. Oncology (2011) 1.10
Gastric cancer surgery in cirrhotic patients: result of gastrectomy with D2 lymph node dissection. World J Gastroenterol (2005) 1.09
Minimally invasive treatment for gastric cancer: approaches and selection process. J Surg Oncol (2005) 1.08